Antiemetic Drugs Market · GlobeNewswire Inc. Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Antiemetic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's ...
Implementing subcutaneous opioid options in the emergency department significantly reduced reliance on intravenous administration.
Purpose: The drug interactions and adverse events that should be considered when individualizing antiemetic therapy for patients undergoing treatment for breast cancer are reviewed. Summary: A variety ...
Please provide your email address to receive an email when new articles are posted on . Over the past two decades, serotonin antagonists have revolutionized the way we prevent and manage ...
Safety of intravenous (IV) NEPA and oral NEPA for prevention of CINV in patients (pts) with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC ...
Antiemetics are a type of medication that can help you feel better when you're nauseated (you feel like throwing up). There are both over-the-counter (OTC) and prescription antiemetics. If you have ...
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. This was a multicenter, randomized, double-blind, ...
The subcutaneous administration of granisetron, an antiemetic pharmaceutical drug (suitable for control of vomiting), achieves similar blood concentrations to those administered intravenously. This ...
A new antiemetic has been approved by the US Food and Drug Administration (FDA) for use in patients undergoing chemotherapy. The new drug, rolapitant (Varubi), has been developed and is marketed by ...
A prospective survey of the control of acute and delayed antineoplastic and radiation-induced nausea and vomiting was undertaken in children undergoing bone marrow transplantation (BMT) at The ...
Chemotherapy-induced nausea and vomiting is an important problem in patients with brain tumors. Because of the high prevalence of seizures, most patients are given antiepileptic drugs. Motivated by a ...
Considerable progress has been made in improving the control of chemotherapy-induced emesis. The impact of available antiemetic options for patients receiving stem cell transplants is unclear, as few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results